LPA suppresses T cell function by altering the cytoskeleton and disrupting immune synapse formation.
LPA suppresses T cell function by altering the cytoskeleton and disrupting immune synapse formation.
复制标题
DOI:
10.1073/pnas.2118816119
复制
发表时间:
2022-04-12
影响因子:
11.1
通讯作者:
中科院分区:
文献类型:
--
作者:
Cancers and chronic infectious pathogens often evade immune-mediated elimination by suppressing T cell function via engaging inhibitory receptors expressed on T cells. The phospholipid lysophosphatidic acid (LPA) is often increased systemically from basal concentrations upon development of cancer and chronic infections. We previously showed that, at these elevated concentrations, LPA suppresses the ability of CD8 T cells to kill malignant cells and to control tumor growth. Here, we demonstrate that LPA signaling suppresses T cell function via disrupting T cell receptor–induced cytoskeletal dynamics, immune synapse formation, signal transduction, and the tubulin code. This report identifies a targetable mechanism of receptor-mediated inhibition of T cell function that could be used in combination therapies to enhance antitumor and antiviral immunity. Cancer and chronic infections often increase levels of the bioactive lipid, lysophosphatidic acid (LPA), that we have demonstrated acts as an inhibitory ligand upon binding LPAR5 on CD8 T cells, suppressing cytotoxic activity and tumor control. This study, using human and mouse primary T lymphocytes, reveals how LPA disrupts antigen-specific CD8 T cell:target cell immune synapse (IS) formation and T cell function via competing for cytoskeletal regulation. Specifically, we find upon antigen-specific T cell:target cell formation, IP3R1 localizes to the IS by a process dependent on mDia1 and actin and microtubule polymerization. LPA not only inhibited IP3R1 from reaching the IS but also altered T cell receptor (TCR)–induced localization of RhoA and mDia1 impairing F-actin accumulation and altering the tubulin code. Consequently, LPA impeded calcium store release and IS-directed cytokine secretion. Thus, targeting LPA signaling in chronic inflammatory conditions may rescue T cell function and promote antiviral and antitumor immunity.
登录
查看更多内容
DOI:
10.4049/jimmunol.182.1.171
发表时间:
2009-01-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Camargo JF;Quinones MP;Mummidi S;Srinivas S;Gaitan AA;Begum K;Jimenez F;VanCompernolle S;Unutmaz D;Ahuja SS;Ahuja SK
通讯作者:
Ahuja SK
影响因子:
20.3
作者:
Baumforth, KRN;Flavell, JR;Murray, PG
通讯作者:
Murray, PG
影响因子:
7.8
作者:
Bartolini, Francesca;Moseley, James B.;Schmoranzer, Jan;Cassimeris, Lynne;Goode, Bruce L.;Gundersen, Gregg G.
通讯作者:
Gundersen, Gregg G.
影响因子:
8.7
作者:
Babich A;Burkhardt JK
通讯作者:
Burkhardt JK
影响因子:
4.8
作者:
Eisenmann, Kathryn M.;West, Richard A.;Alberts, Arthur S.
通讯作者:
Alberts, Arthur S.